Skip to main content
Genesystem Co., Ltd logo

Genesystem Co., Ltd — Investor Relations & Filings

Ticker · 363250 ISIN · KR7363250002 KO Manufacturing
Open in API
Filings indexed 173 across all filing types
Latest filing 2022-03-29 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 363250

About Genesystem Co., Ltd

https://genesystem.co.kr/

Genesystem Co., Ltd. is a biotechnology engineering company specializing in the development and commercialization of molecular diagnostic solutions for point-of-care testing (POCT) applications. The company focuses on making Polymerase Chain Reaction (PCR) testing faster, simpler, and more accessible for on-site use. It develops and markets rapid PCR platforms, proprietary reagents, and biochip-based products. Key technologies include ultra-fast PCR, miniaturized heating modules, and multiplex biochip systems that enable precise and convenient analysis. Genesystem's solutions serve various markets, including human healthcare for pathogen detection and food safety for identifying foodborne pathogens and meat authentication.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific individuals, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and employee compensation via stock options is classified as a Regulatory Filing (RNS) in the absence of a more specific category like 'Director's Dealing' (which usually refers to market transactions) or 'Remuneration' (which usually refers to annual compensation reports).
2022-03-29 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a formal 'Amendment to the Business Report' (정정신고) for the company 'Genesystem' (주식회사 진시스템). It explicitly references the original 'Business Report' (사업보고서) filed on March 21, 2022, and provides specific corrections to sections such as business operations, financial data, and audit information. In the context of Korean corporate filings (DART system), an 'Annual Report' (사업보고서) is the equivalent of a 10-K. Since this document is an official amendment to that annual filing, it is classified under the 10-K category. FY 2021
2022-03-22 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting' (주주총회소집공고) for a company named GeneSystem. It includes details about the meeting agenda, board activities, and management information. In the context of Korean corporate filings (DART system), this type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on agenda items at the upcoming general meeting.
2022-03-22 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a correction filing ('정정신고') for a previously submitted proxy solicitation. It contains information regarding the upcoming Annual General Meeting (AGM), including agenda items, voting procedures, and financial statements for shareholder review. This document is specifically designed to solicit proxies from shareholders for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of the audit opinion, key financial data, and auditor information for the fiscal year. It is a regulatory filing that announces the completion and submission of the audit report to the exchange, rather than the full audit report document itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for the company '주식회사 진시스템' (GeneSystem Co., Ltd.). It includes the independent auditor's report, balance sheet, income statement, statement of changes in equity, cash flow statement, and detailed notes to the financial statements for the fiscal year ending December 31, 2021. Since it contains the full audited financial statements and the auditor's opinion, it is classified as an Audit Report (AR). FY 2021
2022-03-21 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.